Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin L Robb

Showing results (261-270 of 358) with videos related to

Pageof 36
Sort By:
Medicine|August 12, 2016
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AGRichard A Heipertz, Ojor Ayemoba, Eric Sanders-Buell, et al.
Med (New York, N.Y.)|July 23, 2022
Acute HIV-1 infection viremia associate with rebound upon treatment interruptionThembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular CytotoxicityProssy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Journal of Infectious Diseases|July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
Pageof 36

Showing results (261-270 of 358) with videos related to

Sort By:
Pageof 36
Medicine|August 12, 2016
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AGRichard A Heipertz, Ojor Ayemoba, Eric Sanders-Buell, et al.
Med (New York, N.Y.)|July 23, 2022
Acute HIV-1 infection viremia associate with rebound upon treatment interruptionThembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular CytotoxicityProssy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Journal of Infectious Diseases|July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
Pageof 36